Tag Archive for: Director

Jane Weiss Doerr joins Windy Hill Medical as Director of Clinical Affairs

Life Science Partner recruits former Senior Director, Program Management for Genzyme Corporation

Life Science Partner announces the recruitment of Jane Weiss Doerr, RN, MSN, a seasoned oncology clinical trials executive, to Windy Hill Medical as Director of Clinical Affairs.

Windy Hill Medical is a California-based medical device and pharmaceutical company focused on the development of products to reduce the risk of developing breast cancer in patients deemed to be at high risk.

In Doerr’s previous role at Genzyme, a global biotechnology company developing advanced technologies for the treatment of numerous debilitating diseases, she managed a multi-disciplinary global product development team delivering oncology products to the market.  Previously, Doerr was Director and Product Team leader for ILEX Oncology, Inc. where she was responsible for numerous oncology products in various stages of development.  She also served as Senior Vice President for Oncology Research Partners, a national network of academic and community physicians focused on cancer care.

“Jane has a wealth of experience in the oncology clinical and biopharmaceutical industry and is well-grounded as a strategic thinker and operational leader,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “She is very passionate about bringing lasting improvements in healthcare for patients with cancer.”

In her role as Director of Clinical Affairs, Doerr will have the responsibility for managing all phases of Windy Hill’s global clinical trials for the expanding portfolio of compounds under development.  She will collaborate with academic thought leaders, provide strategic direction to the company and build a world-class clinical development team with an eye toward successful FDA and European approvals.

Doerr earned her Bachelor of Science in Nursing at the University of Texas Health Science Center School of Nursing in San Antonio, Texas.  She received a Master of Science in Nursing from the University’s Graduate School of Biomedical Sciences.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

Tom Weber to join Angiotech Pharmaceuticals as Senior Director of Analytical Chemistry

Life Science Partner recruits former Director, Analytical Research and Development of Celator Pharmaceuticals Corporation

Life Science Partner announces the appointment of Tom Weber, a pharmaceutical R & D executive, to Angiotech Pharmaceuticals, Inc., as the Director of Analytical Chemistry.

Angiotech is a world leader in the emerging field of drug-eluting medical devices and biomaterials. With an accelerated program to integrate pharmaceutical and biologically active materials to improve its products, Weber will lead the analytical chemistry team to capitalize upon Angiotech’s considerable intellectual property portfolio to create break-through products.

At Celator Pharmaceuticals, an early-stage biopharmaceutical company developing new combination therapies to treat cancer, Weber led the analytical and bioanalytical development of new products through validation, technical transfer and clinical stage product testing.   As experienced pharmaceutical scientist, he was previously a senior research and development officer in a several early, mid and development stage pharmaceutical companies.

“Weber brings a wealth of experience in the development of new drugs, drug delivery, drug-congugates and drug-device products which will enable him to immediately contribute to Angiotech’s ongoing projects as well as future developmental programs,” noted Cindi Roberts, Vice President at Life Science Partner.

Weber will lead strategic and tactical direction to the Chemistry group within global R&D across multiple complex device platforms including novel pharmaceutical agents and local delivery technology as well as novel combination product development involving local delivery of device platforms.

Weber received his Bachelor of Arts degree in Chemistry and Physics from Gustavus Adolphus College in St. Peter, Minnesota and his PhD in Chemistry from the University of Minnesota.

/0 Comments/by

Hospira Recruits Kurt Gunter, MD, to Lead Cell Therapy Initiatives

Life Science Partner recruit offers valuable experience in regulatory and commercialization strategy

Life Science Partner announces the recruitment of Kurt C. Gunter, MD, as medical director, cell therapy of Hospira, a Chicago area based medical products company.  Hospira is a specialty pharmaceutical and medication delivery company launched from the core global hospital products business of Abbott Laboratories. 

With the recruitment of Gunter, Hospira now has a leader in the field of cell therapy to provide scientific and medical leadership for technology assessment and investment, and manage key relationships with academic and research institutions.  He will have the critical responsibility for representing the cell-therapy companies seeking investment and/or partnership.

“Kurt has a broad background in cell and gene therapy – with a specific expertise in developing regulatory guidelines for the field,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “Few can match his experience in the use of cells for new therapies that hold out the promise to cure intractable diseases.”

As the vice president and medical affairs/governmental relations of ZymeQuest, Gunter led the clinical strategy of a biotechnology company removing A and B antigens from red blood cells to create “universal donor” blood.  Previously, he held a similar role at ViaCell, a cord blood banking and cell therapy company.  His first commercial experience was as vice president, clinical and regulatory for Transkaryotic Therapies (TKT) supervising all regulatory filings for its orphan drug program.

His earlier career was as a researcher and clinical pathologist at Children’s National Medical Center, George Washington University Medical School, and the FDA, where he was acting director, division of cellular and gene therapy.  A recognized leader in the field, he was appointed as the industry representative to the standards-setting organization, the FDA Cellular Tissue and Gene Therapy Advisory Committee.

Gunter earned his BS at Stanford and his MD at University of Kansas School of Medicine, where he also completed his residency.  He continued his anatomical pathology training at University of Maryland and was a biotechnology fellow in molecular immunology at the National Cancer Institute.

Learn More About Chief Medical or Regulatory Leaders
/0 Comments/by

BD Biosciences Recruits Jim Carraher to Become Director, Program Management of Cellular Analysis Business

Life Science Partner recruits proven project management leader at Dade Behring and Syva Company

Life Science Partner announces the placement of James (Jim) D. Carraher, formerly director of program management at Pelikan Technologies, to become the director of program management, cellular analysis business unit at BD Biosciences. 

BD Biosciences, a division of Becton, Dickinson and Company, provides a comprehensive portfolio of reagents, systems and technical expertise to accelerate the pace of biomedical discovery and diagnosis.

In this new role, Carraher will be responsible for the BD Bioscience cellular analysis product development team – speeding products rapidly from concept to prototype to final product in manufacturing and into the research scientist’s laboratory.  Carraher will  accelerate product development for this world leader in flow cytometry solutions for research and clinical use for immune function, vaccine research, infectious disease and oncology.

At Pelikan Technologies, Carraher led an entrepreneurial team to develop the next generation sample acquisition and blood glucose monitoring.  Previously, he was director of project management at Aviron, a vaccine company developing the FluMist delivery system.

“Jim is a top-flight project manager, who has been proven on the international stage,” says Life Science Partner vice president Cindi. Roberts. “He will prove a valuable addition to speeding the commercialization of BD Biosciences’ considerable portfolio.”

Carraher comes to BD Bioscience with more than 20 years of experience developing leading-edge diagnostic products.   In addition to Pelikan Technologies, Carraher has had leadership roles in product management, international marketing and business general management during 20 years at Syva and its successors Behring Diagnostics and Dade Behring. 

While living in Germany during 1996 to 2000 leading global product management for Dade Behring, he introduced the first Customer Advisory Board and Technology Advisory Board that created the Company’s first detailed product lifecycle plan.  The net resulting efficiency was seen in a 17% reduction in manufacturing cost and reduced post-installation service calls.

Learn More About Life Science Partner

Click button below to learn more about we recruit Chief Executives:

Learn More About Chief Executive Functions
/0 Comments/by

Medtronic Hires Kathy Lewis As A Clinical Information Solutions Director

Life Science Partner places IT product development and customer service expert in lead technology role

Life Science Partner announces the placement of Kathy Lewis, MPH, as director for Paceart and clinic practice management solutions at Medtronic, Inc. in Minneapolis.

In this new position, Lewis will lead market analysis and strategic planning efforts, oversee customer relationships, and guide the integration of the company’s Paceart solution with complementary clinical workflow products. Medtronic is one of the world’s leading medical technology companies. Paceart’s scheduling, analysis, device monitoring and other features help healthcare professionals deliver care to arrhythmia patients.

“Kathy is a healthcare IT veteran who has also excelled as a solution-based manager,” says Thomas H. Callaway, Life Science Partner’s founder and president. “At healthcare software start-up Abaton.com, she was responsible for some of the company’s first installations. Her continued success at McKesson demonstrates her effectiveness as a manager, customer service advocate, and both ambulatory and inpatient workflow expert.”

An experienced clinical information technology executive, Lewis complements her product development process knowledge with particularly strong customer skills.

Lewis comes to Medtronic from McKesson Information Solutions. As director of client services there, she led pricing, implementation planning, system transition and ROI evaluation for major new product families. Also previously vice president of product management for the company’s iMcKesson division, she managed a staff of 45 and held responsibility for design, documentation and quality assurance of web-based clinical systems.

Previously, Lewis was director of client services at Abaton.com, managing implementation, training and quality assurance efforts for laboratory, prescription and charting systems. During the company’s acquisition by McKesson, she guided the client services organization’s transition.

Her corporate career began at HealthPartners Medical Group, where Lewis managed a wide range of strategic and operational information systems initiatives.

/0 Comments/by

Proxima Hires Webster for Senior Product Development Position

Life Science Partner connects experienced medical product engineer with radiation delivery systems company:

Life Science Partner announces the placement of R. Michael Webster as senior director of product development at Proxima Therapeutics in Alpharetta, Georgia. In this new capacity, Webster assumes overall responsibility for the development and improvement of products based upon the company’s proprietary delivery system. He will oversee a team of engineers as well as external engineering and manufacturing resources. Proxima Therapeutics, a privately held medical device company, develops innovative radiation delivery systems for the treatment of solid cancerous tumors.

“Michael is regarded by his peers—and the engineers who have served on his teams—as an excellent manager,” says Life Science Partner Vice President Cynthia B. Roberts. “With his start-to-finish engineering expertise from design and development through manufacturing, he’ll prove a strong asset for Proxima.”

Webster is an accomplished project manager with a 17-year career spent engineering balloon and other catheters as well as radiation therapy products. Prior to joining Proxima, Webster was group manager, research and development at Novoste Corporation in Norcross, Georgia. At Novoste, Webster guided strategy, scheduling, budgeting, product development conformity, quality protocols and regulatory efforts.

As program manager with the Balloon Catheter/Stent Delivery Systems Group at Cordis Corporation in Miami Lakes, Florida, Webster led engineering activities on multiple PTCA/PTA delivery system projects. His responsibilities included physician opinion evaluation, product design, competitive product analysis, and portfolio strategies.

Webster initiated his medical device career at North American Instrument Corporation (NAMIC), Glens Falls, New York, where he was senior manufacturing engineer in the project engineering department. With NAMIC, he was task team leader for new product and automation projects including an inflation device for cardiology, radiology drainage bag manufacturing, an introducer sheath, and many more.

During a combined seven years at Coleco Industries and Ingersoll-Rand, Webster also worked as an engineer focused on consumer products and power tools manufacturing.

About Life Science Partner Executive Search

Life Science Partner’s high-quality executive and scientific recruiting services target the very specific needs of life sciences and healthcare organizations. We identify and recruit the brightest talent in the biotechnology, pharmaceutical, medical device and healthcare services fields.

/0 Comments/by

Medtronic Selects Lothar Krinke to Direct Biotechnology Initiatives

Life Science Partner placement offers valuable experience in technology and commercialization assessment

Life Science Partner announces the placement of Lothar Krinke, PhD, as senior director of biosciences technology development for Minneapolis-based Medtronic, Inc. In this new role, Krinke will lead new technology assessment efforts and manage relationships with key external partner institutions. Krinke will also collaborate with Medtronic’s regulatory, clinical and marketing teams to analyze business opportunities in biotechnology and gauge the feasibility of related research programs.

Krinke comes to Medtronic with 13 years of experience in evaluating new medical technologies and lines of business. As a consultant and, more recently, with early stage biotechnology firms, he has demonstrated his ability to assess complex technologies for their commercial potential.

Medtronic, a leading medical technology company, has more than $7 billion in annual revenues.

“With Lothar, Medtronic is gaining a rare combination of applied experience, broad collaboration with companies in the life sciences, and a consultant’s systematic approach to recommending action,” says Life Science Partner Vice President Cynthia B. Roberts. “He will prove a valuable addition to Medtronic’s biotechnology team.”

Prior to Medtronic, Krinke helped found Endogeny Bio Corp. and served as its vice president of business development. He held responsibility for licensing, contracting, intellectual property development and business planning.

Krinke also founded a consulting firm, Biostrategic Solutions, which offers strategic analysis and planning services to biotechnology, pharmaceutical and medical products companies.

At Celera Genomics previously, Krinke was vice president and chief business officer of Celera Online, in which capacity he led the commercial operations of the company’s information business, including marketing, proposals and contracts, client programs, bioinformatics solutions and product strategy. In an earlier position at Celera Genomics, as vice president of business development and strategic planning, Krinke was responsible for strategy, mergers and acquisitions, and licensing. He identified and successfully acquired Axys Pharmaceuticals at that time.

Over ten years as a consultant with McKinsey & Company and, later, A.T. Kearney, Krinke served biopharmaceutical, genomics, medical products and other life sciences companies. His work involved technical assessment and financial valuation, licensing strategy, e-business strategy, corporate transactions and post-merger integration planning, and R&D and commercialization strategy.

Krinke was an American Cancer Society Postdoctoral Research Fellow and a Procter & Gamble Postdoctoral Fellow at the California Institute of Technology. He earned his doctorate in molecular biology at the University at Albany, State University of New York. He holds an undergraduate degree in biology from Technische Universität Braunschweig in Germany.

/0 Comments/by

Life Science Partner Announces Placement of Sherer at Emory University

Life Science Partner announces the placement of Todd T. Sherer as director of the Office of Technology Transfer and assistant vice president for research at Emory University in Atlanta. Sherer will be responsible for patenting, commercializing and licensing healthcare and technologies developed by Emory University faculty.

Most recently director of technology and research collaborations at Oregon Health & Science University in Portland, Sherer managed an annual operating budget of more than $1.8 million.

Sherer previously directed the Office of Technology Transfer at the University of Oregon in Eugene. He held several different positions focusing on intellectual property and research at Washington State University in Pullman, where he also served as adjunct assistant professor at the College of Pharmacy.

Sherer holds a doctorate from Washington State University and a bachelor of science from Oregon State University.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Learn More About Chief Executive Functions
/0 Comments/by